Status:
COMPLETED
QuickOpt Chronic Study
Lead Sponsor:
Abbott Medical Devices
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to demonstrate that QuickOpt optimization can be as an alternative method for CRTP/D patients' optimization in clinical practice through the comparison of the improvement ...
Detailed Description
Clinical studies have demonstrated that the AVTI from QuickOptTM related significantly to the max aorta VTI (AVTI) by Echo, the concordance correlation coefficient (CCC) was so high from 0.96 to 0.99....
Eligibility Criteria
Inclusion
- • Patient meets current CRT-P indications and be implanted with an SJM CRT-P device with V-V timing and a compatible lead system
- Patient is able to provide written informed consent for study participation
Exclusion
- • Patient has limited intrinsic atrial activity (≤ 40 bpm)
- Patient has persistent or permanent AF
- Patient has a 2o or 3o heart block
- Patient's life expectancy is \<12 months
- Patient is \<18 years old
- Patient is pregnant
- Patient is on IV inotropic agents
- Patients who are ongoing other devices or agents study
- Patients with heart transplanted or waiting for heart transplant
- Patients with Hypertrophic and obstructive cardiomyopathy
- Patients with severe aortic valve and mitral valve stenosis or regurgitation without replacement
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01172067
Start Date
May 1 2010
End Date
January 1 2016
Last Update
October 8 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, Beijing Municipality, China, 100037